CASI Pharmaceuticals had $10.8M loss in 2017
Grow Your Business in Maryland with digital marketing services from The W Agency
Rockville-based biopharmaceutical company CASI Pharmaceuticals reported a net loss of $10.8 million in financial statements released Thursday. Company officials attribute the loss to costs associated with CFDA quality testing in support of CASI’s application for import drug registration of two drugs, offset by less non-cash stock compensation expense during 2017. Despite the loss, CASI Executive ...
from https://ift.tt/2urBFeQ
Digital Marketing Agency in Maryland
Rockville-based biopharmaceutical company CASI Pharmaceuticals reported a net loss of $10.8 million in financial statements released Thursday. Company officials attribute the loss to costs associated with CFDA quality testing in support of CASI’s application for import drug registration of two drugs, offset by less non-cash stock compensation expense during 2017. Despite the loss, CASI Executive ...
from https://ift.tt/2urBFeQ
Digital Marketing Agency in Maryland
Comments
Post a Comment